https://www.fredhutch.org/en/news/releases/rss2016-05-17T03:04:58.536ZNews Releases RSS FeedAdobe Experience ManagerTelephone-based cognitive behavioral therapy significantly improves menopause symptomsChatting on the phone with a “sleep coach” and keeping a nightly sleep diary significantly improve sleep quality and reduce insomnia in women through all stages of menopause, according to a new study published today in JAMA Internal Medicine. The study also found that such phone-based cognitive behavioral therapy significantly reduced the degree to which hot flashes, or vasomotor symptoms, interfered with daily functioning.
https://www.fredhutch.org/en/news/releases/2016/05/phone-based-therapy-improve-menopause-symptoms2016-05-23T15:00:00.000Z2016-05-23T15:00:00.000ZFred Hutch hires Steve Stadum as executive vice president and chief operating officerFred Hutchinson Cancer Research Center today announced the hiring of Steve Stadum as executive vice president and chief operating officer. Stadum, currently the chief operating officer of Oregon Health & Science University’s Knight Cancer Institute, played a central role in securing $1 billion in financing to launch a vast expansion of the Portland-based institute. On July 5, he will join Fred Hutch as a key member of President and Director Dr. Gary Gilliland’s staff.
https://www.fredhutch.org/en/news/releases/2016/04/steve-stadum-new-fred-hutch-evp-and-coo2016-04-29T18:28:06.000Z2016-04-29T18:28:06.000ZFred Hutch President and Director Gary Gilliland elected to American Academy of Arts and Sciences Dr. Gary Gilliland, president and director of Fred Hutchinson Cancer Research Center, has been elected to membership in the American Academy of Arts and Sciences, one of the nation’s oldest and most prestigious honorary societies and independent policy-research centers.https://www.fredhutch.org/en/news/releases/2016/04/gary-gilliland-elected-american-academy-arts-sciences2016-04-20T08:30:00.000Z2016-04-20T08:30:00.000ZFred Hutch's Obliteride lights the sky orange to help cure cancer fasterStarting today – coinciding with Vice President Joe Biden’s visit to Fred Hutchinson Cancer Research Center to discuss the cancer “moonshot”– and running through April 8, Obliteride’s supporters and partners will light the Seattle skyline orange to show their commitment to help Fred Hutch cure cancer. The Pacific Science Center arches, The Great Wheel, REI climbing rock, Columbia Tower, IBM Plaza and Union Square are just a few of the structures turning “Obliteride orange.”https://www.fredhutch.org/en/news/releases/2016/03/obliteride-lights-sky-orange2016-03-21T17:29:14.000Z2016-03-21T17:29:14.000ZFred Hutch researcher receives grant for esophageal cancer screening studyDr. William Grady, a clinical researcher and cancer geneticist at Fred Hutch, has been awarded a $180,000 grant from the DeGregorio Family Foundation for Gastric and Esophageal Cancer Research and the Price Family Foundation for a two-year project to develop a better way to identify people at highest risk for esophageal adenocarcinoma, the most common cancer of the esophagus. https://www.fredhutch.org/en/news/releases/2016/03/hutch-researcher-gets-grant-for-esophageal-cancer-screening-study2016-03-10T19:44:37.000Z2016-03-10T19:44:37.000ZFred Hutch announces 2016 Harold M. Weintraub Graduate Student Awardeeshttps://www.fredhutch.org/en/news/releases/2016/03/fred-hutch-announces-2016-weintraub-awardees2016-03-01T13:00:00.000Z2016-03-01T13:00:00.000ZJuno Therapeutics, Seattle Cancer Care Alliance and Fred Hutchinson Cancer Research Center announce new immuno-oncology clinical trials unithttps://www.fredhutch.org/en/news/releases/2016/02/juno-therapeutics-fred-hutch-announce-immuno-oncology-clinical-trials-unit2016-02-24T00:58:04.000Z2016-02-24T00:58:04.000ZShop and dine to help fund women’s cancer research at Fred Hutchhttps://www.fredhutch.org/en/news/releases/2016/02/shop-dine-to-fund-womens-cancer-research2016-02-08T20:02:11.000Z2016-02-08T20:02:11.000ZPhone counseling found insufficient to help teen smokers stay quit into young adulthoodIn a 14-year study involving more than 2,000 teen smokers in 50 Washington state high schools, a team of cancer prevention researchers at Fred Hutchinson Cancer Research Center has found that one year of telephone counseling using motivational interviewing and skills training delivered during the senior year of high school is insufficient to help the smokers quit and stay quit up to six years into young adulthood. https://www.fredhutch.org/en/news/releases/2016/02/phone-couseling-insufficient-to-help-teen-smokers-stay-quit2016-02-01T19:24:40.000Z2016-02-01T19:24:40.000ZShedding new light on breast cancer metastasisIt has long been thought that cancer metastasizes, or spreads, when a single cancer cell escapes from the original tumor, travels through the bloodstream and sets up shop in distant organs. However, a growing body of evidence suggests that these bad actors don’t travel alone; instead they migrate through the body in cellular clusters, like gangs.https://www.fredhutch.org/en/news/releases/2016/02/shedding-new-light-on-breast-cancer-metastasis2016-02-01T19:00:00.000Z2016-02-01T19:00:00.000Z Fred Hutch joins nation's cancer centers in endorsing HPV vaccinationhttps://www.fredhutch.org/en/news/releases/2016/01/fred-hutch-joins-us-cancer-centers-to-endorse-hpv-vaccination2016-01-27T19:44:54.000Z2016-01-27T19:44:54.000ZSt. Louis Cardinals ace Adam Wainwright named 51st Hutch Award winnerAdam Wainwright, a Major League Baseball star pitcher who also hurls his energy into humanitarian causes, has won the 51st annual Hutch Award. A veteran starter for the St. Louis Cardinals, Wainwright will accept the honor at the 2016 Hutch Award Luncheon, which will be held Jan. 27 at Safeco Field in Seattle — home city of big league pitcher and manager Fred Hutchinson and the cancer research center that bears his name. https://www.fredhutch.org/en/news/releases/2015/12/st-louis-cardinals-adam-wainwright-51st-hutch-award-winner2015-12-17T02:00:00.000Z2015-12-17T02:00:00.000ZSpace Needle Foundation Donates $510,000 to Fred Hutch On Oct. 3, 2015, almost 1,200 participants climbed the 832 stairs of Seattle’s landmark Space Needle, raising more than $510,000 for cancer research at Fred Hutchinson Cancer Research Center. https://www.fredhutch.org/en/news/releases/2015/11/space-needle-foundation-donates-to-fred-hutch2015-11-26T04:45:00.000Z2015-11-26T04:45:00.000ZBetter help for menopausal womenDr. Katherine A. Guthrie, a biostatistician in the Public Health Sciences Division at Fred Hutchinson Cancer Research Center, is co-leading a $7 million grant for a multicenter clinical trial that will compare popular treatments for menopause-related vaginal symptoms ranging from dryness and atrophy (thinning and shrinking of the tissues) to itching, irritation and painful intercourse.https://www.fredhutch.org/en/news/releases/2015/11/better-help-for-menopausal-women2015-11-05T22:43:31.000Z2015-11-05T22:43:31.000ZFred Hutch's Obliteride sets new fundraising recordFred Hutch’s Obliteride climbs to a record $2.65 million in its third year, bringing in more money for a nonprofit organization than any other bike ride in the Pacific Northwest. To date, Obliteride has raised nearly $7 million for lifesaving cancer research at Fred Hutchinson Cancer Research Center. https://www.fredhutch.org/en/news/releases/2015/10/obliteride-sets-new-fundraising-record2015-10-30T02:00:00.000Z2015-10-30T02:00:00.000ZImmunotherapy for pancreatic cancer boosts survival by more than 75% in miceA new study in mice by researchers at Fred Hutchinson Cancer Research Center has found that a specialized type of immunotherapy — even when used without chemotherapy or radiation — can boost survival from pancreatic cancer, a nearly almost-lethal disease, by more than 75 percent. The findings are so promising, human clinical trials are planned within the next year.https://www.fredhutch.org/en/news/releases/2015/10/immunotherapy-for-pancreatic-cancer-boosts-survival-in-mice2015-10-29T17:50:53.000Z2015-10-29T17:50:53.000ZFindings on immune response inform direction of HIV vaccine developmentA review article by Fred Hutch's Dr. Larry Corey published today in Science Translational Medicine looks at findings gleaned in the past four years describing types of immune responses that a preventive HIV vaccine may need to achieve protection against acquiring HIV infection.
https://www.fredhutch.org/en/news/releases/2015/10/findings-on-immune-response-inform-hiv-vaccine-development2015-10-21T19:53:21.000Z2015-10-21T19:53:21.000ZFred Hutch President and Director Dr. Gary Gilliland elected to National Academy of MedicineFred Hutchinson Cancer Research Center President and Director Gary Gilliland, M.D., Ph.D., has been elected to the National Academy of Medicine (formerly known as the Institute of Medicine). Election to NAM is considered to be one of the highest honors in the fields of health and medicine, and it recognizes individuals who have demonstrated outstanding professional achievement and commitment to service.https://www.fredhutch.org/en/news/releases/2015/10/gary-gilliland-elected-to-national-academy-of-medicine2015-10-19T16:14:46.000Z2015-10-19T16:14:46.000Z10 Major League Baseball players nominated for 2015 Hutch AwardTen Major League Baseball players — including sluggers Andrew McCutchen and Adrian Beltre — were nominated today for the annual Hutch Award, one of the game’s most respected, humanitarian accolades. https://www.fredhutch.org/en/news/releases/2015/10/10-mlb-players-nominated-2016-hutch-award2015-10-16T19:47:40.000Z2015-10-16T19:47:40.000ZCommunity invited to Fred Hutch 40th anniversary block partyhttps://www.fredhutch.org/en/news/releases/2015/09/community-invited-to-fred-hutch-40th-anniversary-block-party2015-09-08T19:41:34.000Z2015-09-08T19:41:34.000Z